Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06791057 · ClinicalTrials.gov registry record · NA
Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 420
- Enrollment target
NCT06791057: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT06791057 is a NA study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 420 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06791057, a NA study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
Study Summary
Dyspnea, or breathlessness, is one of the most common and distressing symptoms experienced by patients with advanced lung cancer. The purpose of this multi-site trial is to test the effectiveness of a dyspnea intervention (called BREEZE+) that includes three brief nurse-delivered sessions and access to a digital health app that teaches and reinforces patients' use of skills for managing and coping with this highly debilitating symptom. This study will lay the groundwork for a follow-up pragmatic implementation trial integrating BREEZE+ into usual oncology care for patients with advanced lung cancer experiencing dyspnea.
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Dyspnea Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2030-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06791057
The ClinicalTrials.gov registry entry for NCT06791057 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT06791057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06791057 about?
NCT06791057 is a clinical study titled "Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer". Dyspnea, or breathlessness, is one of the most common and distressing symptoms experienced by patients with advanced lung cancer. The purpose of this multi-site trial is to test the effectiveness of a dyspnea intervention (called BREEZE+) that includes three brief nurse-delivered sessions and access...
What is the current status of trial NCT06791057?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 420 participants. The study started on 2026-09-01. Estimated completion is 2030-03-31.
What interventions are being tested in trial NCT06791057?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Dyspnea Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06791057?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.